Human Plasma-Derived, Nanofiltered, C1-Inhibitor Concentrate (Cinryze®), a Novel Therapeutic Alternative for the Management of Hereditary Angioedema Resulting from C1-Inhibitor Deficiency
Biologics in Therapy · 2012
DOI: 10.1007/s13554-012-0002-5 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biologics in Therapy, 2012. Verfasst von Henriette Farkas und 1 weiteren Autor:innen. Beteiligte Einrichtung: 3rd Department of Internal Medicine, Semmelweis University, Kutvolgyi ut 4, H-1225 Budapest, Hungary. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- 3rd Department of Internal Medicine, Semmelweis University, Kutvolgyi ut 4, H-1225 Budapest, Hungary.
Zitieren
APA
Farkas, H., & Varga, L. (2012). Human Plasma-Derived, Nanofiltered, C1-Inhibitor Concentrate (Cinryze®), a Novel Therapeutic Alternative for the Management of Hereditary Angioedema Resulting from C1-Inhibitor Deficiency. Biologics in Therapy. https://doi.org/10.1007/s13554-012-0002-5
Vancouver
Farkas H, Varga L. Human Plasma-Derived, Nanofiltered, C1-Inhibitor Concentrate (Cinryze®), a Novel Therapeutic Alternative for the Management of Hereditary Angioedema Resulting from C1-Inhibitor Deficiency. Biologics in Therapy. 2012. doi:10.1007/s13554-012-0002-5
BibTeX
@article{Farkas2012,
author = {Farkas, Henriette and Varga, Lilian},
title = {Human Plasma-Derived, Nanofiltered, C1-Inhibitor Concentrate (Cinryze®), a Novel Therapeutic Alternative for the Management of Hereditary Angioedema Resulting from C1-Inhibitor Deficiency},
journal = {Biologics in Therapy},
year = {2012},
doi = {10.1007/s13554-012-0002-5}
}
EUVIMED